Parafleet SC 014 PTA Balloon Dilatation Catheter
06942265500922
5manufacturers in China registered for this device type
572catalogue numbers in this listing
4510(k) clearances naming this product code
1recall
Who Else Makes It
Concentrated in Jiangsu (3), Guangdong (2).
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| OrbusNeich Medical (Shenzhen) Co., Ltd. | Shenzhen | Guangdong | Complaint-file establishment | 5 |
| Curatia Medical Limited | Suzhou | Jiangsu | Specification developer | 5 |
| Brosmed Medical Co., Ltd. | Dongguan | Guangdong | Contract manufacturer | 4 |
| Kossel Medtech (Suzhou) Co., Ltd. | Suzhou | Jiangsu | Manufacturer | 4 |
| DK Medical Technology Co., Ltd. | Suzhou | Jiangsu | Manufacturer | 3 |
Record
| Listed by | Brosmed Medical Co., Ltd., China |
|---|---|
| FDA product code | LIT |
| Device type | Catheter, Angioplasty, Peripheral, Transluminal |
| Device class | Class 2 |
| Regulation | 21 CFR 870.1250 |
| Establishment | Contract manufacturer, Specification developer, Manufacturer |
| Record published | 2025-05-10 |
| Record revised | 2025-11-24 (version 2) |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Supplied sterile | Yes |
| Single use | Yes |
| Latex | Contains natural rubber latex |
| Label carries | lot or batch number, expiry date, manufacturing date, serial number |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution | |
| rev 02 | In distribution |
Showing 250 of 300 catalogue numbers.
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Parafleet SC 018 PTA Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | 1,460 |
| Jade Plus PTA Balloon Dilatation Catheter / Jade Plus 18 OTW | OrbusNeich Medical (Shenzhen) Co., Ltd. | 832 |
| Jade PTA Balloon Dilatation Catheter | OrbusNeich Medical (Shenzhen) Co., Ltd. | 667 |
| Minerva PTA Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | 504 |
| Advocate | Arravasc, Ltd. | 441 |
| Ultraverse® 035 PTA Dilatation Catheter | Bard Peripheral Vascular, Inc. | 361 |
| Polux PTA Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | 359 |
| Advance | Cook Incorporated | 355 |
| Pacific™ Plus | Medtronic, Inc. | 347 |
| EverCross™ | ev3, Inc. | 316 |
| Achilles NC PTA Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | 297 |
| Castor NC PTA Balloon Dilatation Catheter | Brosmed Medical Co., Ltd. | 297 |
Showing 12 of 167. All products under Catheter, Angioplasty, Peripheral, Transluminal
510(K) Clearances
| Clearance | Decision date |
|---|---|
| K243704 | 2025-02-27 |
| K212215 | 2022-07-19 |
| K160941 | 2016-12-13 |
| K160256 | 2016-07-29 |
Recalls
1 of these is Class II. Class II means a temporary or reversible health consequence. Volume alone is not a quality signal: a manufacturer that ships more recalls more.
| Initiated | FDA class | Root cause | Reason | Quantity | Closed |
|---|---|---|---|---|---|
| 2018-12-14 | Class II | Employee error | Incorrect (higher) Rated Burst Pressure information printed on label. | 400 | 2020-12-11 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.